Research design
This study followed the Consolidated Standards of Reporting Trials (CONSORT) guidelines, utilizing a randomized controlled trial (RCT) design. This RCT was conducted between the beginning of September 2022 and the middle of January 2023, following rigorous guidelines to ensure the validity and reliability of the study’s results. The study employed a two-arm, single-blind approach, including pre-test, post-test, and follow-up measurements, with a waiting list of control groups. The study was registered under the reference number NCT05721339.